These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14697989)

  • 41. Thyroid function in children after allogeneic bone marrow transplantation.
    Borgström B; Bolme P
    Bone Marrow Transplant; 1994 Jan; 13(1):59-64. PubMed ID: 8019454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
    Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect on growth parameters of bone marrow transplantation with a chemotherapy-only conditioning regimen.
    Khoshniat M; Ghavamzadeh A; Larijani B; Bahar B; Tabatabaei O
    Transplant Proc; 2003 Dec; 35(8):3085-8. PubMed ID: 14697985
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning.
    Slatter MA; Gennery AR; Cheetham TD; Bhattacharya A; Crooks BN; Flood TJ; Cant AJ; Abinun M
    Bone Marrow Transplant; 2004 May; 33(9):949-53. PubMed ID: 15004542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group.
    Matthay KK; Seeger RC; Reynolds CP; Stram DO; O'Leary MC; Harris RE; Selch M; Atkinson JB; Haase GM; Ramsay NK
    J Clin Oncol; 1994 Nov; 12(11):2382-9. PubMed ID: 7964954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON).
    Muñoz A; Bureo E; Ortega JJ; Richard C; Olivé T; Maldonado MS; Madero L; Díaz MA
    Haematologica; 1998 Nov; 83(11):981-4. PubMed ID: 9864916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
    Matsuyama T; Kojima S; Kato K
    Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Late onset of renal dysfunction in survivors of bone marrow transplantation.
    Tarbell NJ; Guinan EC; Niemeyer C; Mauch P; Sallan SE; Weinstein HJ
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):99-104. PubMed ID: 2968967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan.
    Carpenter PA; Marshall GM; Giri N; Vowels MR; Russell SJ
    Bone Marrow Transplant; 1996 Sep; 18(3):489-94. PubMed ID: 8879607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth in homozygous beta-thalassemia after bone marrow transplantation.
    Ponte G; Ferrara M; Esposito L
    Bone Marrow Transplant; 1991; 8 Suppl 1():68-9. PubMed ID: 1760650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyroid dysfunction among long-term survivors of bone marrow transplantation.
    Sklar CA; Kim TH; Ramsay NK
    Am J Med; 1982 Nov; 73(5):688-94. PubMed ID: 6753576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study.
    Woods WG; Kobrinsky N; Buckley J; Neudorf S; Sanders J; Miller L; Barnard D; Benjamin D; DeSwarte J; Kalousek D
    J Clin Oncol; 1993 Aug; 11(8):1448-57. PubMed ID: 8336184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission.
    Blaise D; Gaspard MH; Stoppa AM; Michel G; Gastaut JA; Lepeu G; Tubiana N; Blanc AP; Rossi JF; Novakovitch G
    Bone Marrow Transplant; 1990 Jan; 5(1):7-12. PubMed ID: 2404531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission.
    Ganem G; Kuentz M; Bernaudin F; Gharbi A; Cordonnier C; Lemerle S; Karianakis G; Vinci G; Rochant H; Lebourgeois JP
    Cancer; 1989 Nov; 64(9):1796-804. PubMed ID: 2676139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary function after autologous bone marrow transplantation in children: a long-term prospective study.
    Frisk P; Arvidson J; Bratteby LE; Hedenström H; Lönnerholm G
    Bone Marrow Transplant; 2004 Mar; 33(6):645-50. PubMed ID: 14688819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin's lymphoma.
    Bernard M; Dauriac C; Drénou B; Leberre C; Branger B; Fauchet R; Le Prisé PY; Lamy T
    Bone Marrow Transplant; 1999 Feb; 23(4):329-33. PubMed ID: 10100576
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone marrow transplantation for childhood leukemia: five years' experience in a pediatric hematology center.
    Uderzo C; Locasciulli A; Rovelli A; Rossi MR; Jankovic M; Adamoli L; Bonomi M; Balduzzi A; Biondi A; Schirò R
    Haematologica; 1992; 77(3):257-64. PubMed ID: 1427433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.
    Harousseau JL; Attal M; Divine M; Milpied N; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M
    Bone Marrow Transplant; 1995 Jun; 15(6):963-9. PubMed ID: 7581098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome of second bone marrow transplantation following a uniform conditioning regimen as therapy for malignant relapse.
    Chiang KY; Weisdorf DJ; Davies SM; Enright H; Kersey JH; McGlave PB; Miller W; Ramsay NK; Steinbuch M; Wagner JE; Blazar BR
    Bone Marrow Transplant; 1996 Jan; 17(1):39-42. PubMed ID: 8673052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.